These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12412387)

  • 1. Legislative and ethical aspects of administering granulocyte colony-stimulating factor to normal donors.
    De Silvestro G; Marson P; Cesaro S; Messina C
    Haematologica; 2002 Aug; 87(8 Suppl):28-34. PubMed ID: 12412387
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
    Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible harmful effects of short course granulocyte colony-stimulating factor in normal donors.
    Goldman JM; Madrigal JA; Pamphilon D
    Br J Haematol; 2006 Dec; 135(5):651-2. PubMed ID: 17054429
    [No Abstract]   [Full Text] [Related]  

  • 4. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.
    de la Rubia J; de Arriba F; Arbona C; Pascual MJ; Zamora C; Insunza A; Martínez D; Paniagua C; Díaz MA; Sanz MA
    Haematologica; 2008 May; 93(5):735-40. PubMed ID: 18387976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective.
    Bargetzi MJ; Passweg J; Baertschi E; Schoenenberger A; Gwerder C; Tichelli A; Burger J; Mingrone W; Herrmann R; Gratwohl A; Wernli M
    Bone Marrow Transplant; 2003 Jan; 31(2):99-103. PubMed ID: 12621490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive parameters for granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization.
    Okano A; Ashihara E; Shimazaki C; Uchiyama H; Inaba T; Taniguchi K; Maekawa T; Taniwaki M
    J Clin Apher; 2008; 23(6):171-7. PubMed ID: 18988229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rapid determination of optimal time for peripheral blood stem cell harvest by detecting hematopoietor progenitor cell during mobilization].
    Guo JJ; Wu SY; Chen YL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):570-3. PubMed ID: 16320591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial regeneration induced by granulocyte-colony-stimulating factor mobilization of stem cells in patients with acute or chronic ischaemic heart disease: a non-invasive alternative for clinical stem cell therapy?
    Kastrup J; Ripa RS; Wang Y; Jørgensen E
    Eur Heart J; 2006 Dec; 27(23):2748-54. PubMed ID: 17065171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of factors for poor mobilization after administration of recombinant human granulocyte stimulating factor (rHuG-CSF) in healthy donors].
    Aoyama Y; Nakamae H; Yamamura R; Makita K; Shima E; Hasegawa T; Sakamoto C; Kho G; Ohta K; Yamane T; Takubo T; Hino M
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):829-36. PubMed ID: 12852351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
    Suzuya H; Watanabe T; Nakagawa R; Watanabe H; Okamoto Y; Onishi T; Abe T; Kawano Y; Kagami S; Takaue Y
    Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease.
    Gaia S; Smedile A; Omedè P; Olivero A; Sanavio F; Balzola F; Ottobrelli A; Abate ML; Marzano A; Rizzetto M; Tarella C
    J Hepatol; 2006 Jul; 45(1):13-9. PubMed ID: 16635534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of serum high-mobility group box 1 protein during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilisation.
    Tagami K; Yujiri T; Tanimura A; Mitani N; Nakamura Y; Ariyoshi K; Ando T; Fujii Y; Tanizawa Y
    Br J Haematol; 2006 Nov; 135(4):567-9. PubMed ID: 17054673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of cytokine-stimulated healthy donors in allogeneic stem cell transplantation.
    Cesaro S; Marson P; Gazzola MV; De Silvestro G; Destro R; Pillon M; Calore E; Messina C; Zanesco L
    Haematologica; 2002 Aug; 87(8 Suppl):35-41. PubMed ID: 12412388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'In vivo' time course of plasma myeloperoxidase levels after granulocyte colony-stimulating factor-induced stem cell mobilization.
    Morabito F; Tomaino A; Cristani M; Martino M; Minciullo PL; Saija A; Gangemi S
    Transfus Med; 2005 Oct; 15(5):425-8. PubMed ID: 16202058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used.
    Ings SJ; Balsa C; Leverett D; Mackinnon S; Linch DC; Watts MJ
    Br J Haematol; 2006 Sep; 134(5):517-25. PubMed ID: 17018030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease.
    Ripa RS; Wang Y; Jørgensen E; Johnsen HE; Hesse B; Kastrup J
    Eur Heart J; 2006 Aug; 27(15):1785-92. PubMed ID: 16825290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of stem cell donation modality on normal donor quality of life: a prospective randomized study.
    Kennedy GA; Morton J; Western R; Butler J; Daly J; Durrant S
    Bone Marrow Transplant; 2003 Jun; 31(11):1033-5. PubMed ID: 12774056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of the content of plasma protein carbonyl groups in donors after granulocyte colony stimulating factor-induced stem cell mobilization.
    Morabito F; Tomaino A; Cristani M; Cimino F; Martino M; Minciullo PL; Calabrò C; Saija A; Gangemi S
    Transfus Apher Sci; 2005 Oct; 33(2):141-6. PubMed ID: 16103013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mobilization of peripheral blood stem cells with mitoxantrone and high-dose cytarabine chemotherapy and rhG-CSF in patients with hematopoietic malignancies].
    Qiu HY; Wu DP; Sun AN; Chang WR; Jin ZM; Miao M; Tang XW; Shen YM; Fu ZZ
    Zhonghua Xue Ye Xue Za Zhi; 2004 Aug; 25(8):462-5. PubMed ID: 15555260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.